RTP Biopharma Happy Hour: Connect, Collaborate & Innovate

Overview

Join Novogene and industry partners on July 31 for an afternoon of networking with scientists, biopharma leaders, and life science professionals across the RTP community.

Enjoy complimentary food and beverages while connecting with researchers, decision-makers, and innovators
shaping the future of biopharma research and development.

What to expect

Discover Novogene’s sequencing and multi-omics solutions
Engage with industry experts and innovation leaders
Explore new opportunities for collaboration and partnership

July 31, 2026 3:00pm - July 31, 2026 6:00pm

NCBiotech
15 TW Alexander Drive
Durham, NC 27713

No Cost

BiomanufacturingNetworking

July 23, 2026

Atsena Therapeutics reaches phase 3 milestone for gene therapy targeting X-linked retinoschisis

Durham-based Atsena Therapeutics, a clinical-stage gene therapy company focused on using genetic medicine to reverse or prevent blindness, has dosed the first patient in the Phase 3 pivotal cohort of the LIGHTHOUSE trial evaluating its ATSN-201 gene therapy for the treatment of X-linked retinoschisis (XLRS).

July 22, 2026

Kymanox opens Formulation Lab to address early drug development challenges

Kymanox has opened a new Formulation Lab to provide formulation development and analytical testing services for pharmaceutical and biotechnology companies moving programs from early research into clinical manufacturing.

July 21, 2026

Raleigh-based CRO Caidya expands global reach with UK-based CRO

Caidya, a global clinical research organization based in Raleigh, has announced it is combining with UK-based CRO Simbec-Orion to create a new platform to accelerate drug development programs and international scale-up. The combined company will operate under the Caidya name, the announcement said.